Completed PHASE2 INTERVENTIONAL 1-arm NCT00107991

Etanercept for Treatment of Hidradenitis

A Phase II Open Label Clinical Trial of Etanercept for the Treatment of Hidradenitis Suppurativa

Sponsor: University of Pennsylvania

Interventions etanercept

Updated 6 times since 2017 Last updated: Mar 19, 2018 Started: Apr 30, 2005 Primary completion: Aug 31, 2008 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Hidradenitis Suppurativa and is currently completed. University of Pennsylvania leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Dec 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Dec 2021 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Pennsylvania

Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.